Dolby Labs rated Buy for strong margins, buybacks, and undervalued shares despite slow growth

Dolby Laboratories is rated a Buy due to its high gross margin of around 90%, strong operating leverage, and a robust share buyback program authorized up to $427 million. Despite weak revenue growth and stagnant licensing, Dolby's earnings per share (EPS) can grow through margin strength and buybacks, potentially supporting a 15x price-to-earnings multiple and over 20% upside. The current valuation limits downside risk, and any stabilization or growth in licensing could unlock additional upside potential. This makes Dolby an attractive investment despite its slow top-line growth.

Dolby Laboratories has a market cap of $5.50 billion and a dividend yield of 2.45%, highlighting its value proposition despite slow revenue growth. On Pluang, Dolby's shares trade at USD 58.89 with a modest 0.20% increase as of Oct 05, 2026 13:21 WIB. The stock's enterprise value stands at $4.88 billion, reflecting investor interest in the company's strong margins and buyback program.